Patient smiling at the camera
JELMYTO: A treatment plan that works for you

Preparing for treatment with Jelmyto

Illustration depicts a bottle of prescription medication

Before Jelmyto is given, you will need to take sodium bicarbonate. Your doctor will give you instructions on how to take this. You will need to take this each time you get Jelmyto.

Things to discuss with your doctor:

  • Let your doctor know if you are taking a water pill (diuretic)
  • Tell your doctor if you have any other medical conditions or take any other medications. There is a chance that your doctor may tell you to take additional medicine, or change the medication that you are currently taking, once you start treatment with Jelmyto
  • Discuss whether general anesthesia is right for you. This is not required for Jelmyto, but only the two of you can decide if this, or any other form of medication, is needed

Doctor Discussion Guide

If you're thinking about treatment with JELMYTO, this discussion guide will help you ask the right questions at your next doctor's visit.

Download the guideDownload icon

Starter Kit

Designed to support people who have been prescribed Jelmyto. It includes an Educational Brochure with information about what to expect from treatment and a Treatment Tracker to help you stay on track while receiving Jelmyto.

Download the kitDownload icon

What to expect when receiving Jelmyto

Jelmyto is given as an outpatient treatment, and you will typically be sent home the same day.

Illustration depicts patient entering through a door

Jelmyto treatment is given at a clinic, hospital, or ambulatory surgery center, and you generally don’t have to stay overnight.

Illustration depicts a kidney injected with Jelmyto

Jelmyto offers a choice of instillation: a nephrostomy tube or a ureteral catheter.

Jelmyto is given once a week for 6 weeks. Anesthesia or a sedative may be given but is not required.

What to expect after treatment with Jelmyto

Take precautions when you urinate

Jelmyto may cause your urine to turn a violet to blue color after treatment, but your urine flow should otherwise be normal. However, Jelmyto contains chemotherapy, so it is important to be careful when you urinate after treatment. Please follow these instructions when you’re at home:

  • Avoid contact with urine for at least 6 hours after the treatment
  • Male and female patients both should sit on a toilet, and flush the toilet several times after use
  • Wash your hands, inner thighs, and groin with soap and water after urination
  • Wash clothing right away and by itself (not with other clothes) if any urine gets on them

For sexually active patients

For Women:

  • Do not become pregnant during treatment with Jelmyto. If you become pregnant, contact your doctor immediately
  • Use effective birth control (contraception) during treatment with Jelmyto and for 6 months after the last dose
  • Do not breastfeed during treatment with Jelmyto
Illustration depicts a man and woman

For Men:

  • If you have a female partner who may become pregnant, use effective birth control during treatment with Jelmyto and for 3 months after the last dose

Follow-up visits after finishing treatment with Jelmyto

After your last treatment of Jelmyto, your healthcare provider will schedule regular check-ups to monitor how you are doing.

Various tests or procedures may be used during your visits. Some may be the same ones you had when you were first diagnosed and treated.

  • Upper tract endoscopy/ureteroscopy: a long flexible tube with a tiny camera is used to check your urinary tract and kidneys
  • Imaging: an MRI or CT scan is used to look at the entire urinary tract area

You can also use these appointments to go over any questions or concerns you have. If you notice any new symptoms between appointments, tell your healthcare provider right away.

Taking care of yourself after treatment

Dealing with cancer is a stressful experience. Resting and maintaining a healthy lifestyle after finishing treatment can help your body recover and improve your well-being.

It is natural to feel worried after treatment and in between follow-up visits. Having a strong support system and spending time with family and friends can help you stay positive. There are also support groups available. They can connect you with other people who are fighting cancer and who know what you are going through.

Doctor Discussion Guide

If you're thinking about treatment with JELMYTO, this discussion guide will help you ask the right questions at your next doctor's visit.

Download the guideDownload icon

Starter Kit

Designed to support people who have been prescribed Jelmyto. It includes an Educational Brochure with information about what to expect from treatment and a Treatment Tracker to help you stay on track while receiving Jelmyto.

Download the kitDownload icon

Approved Use for Jelmyto

Jelmyto® is a prescription medicine used to treat adults with a type of cancer of the lining of the upper urinary tract including the kidney called low-grade Upper Tract Urothelial Cancer (LG-UTUC).

Important Safety Information

You should not receive Jelmyto if you have a hole or tear (perforation) of your bladder or upper urinary tract.

Before receiving Jelmyto, tell your healthcare provider about all your medical conditions, including if you
  • are pregnant or plan to become pregnant. Jelmyto can harm your unborn baby. You should not become pregnant during treatment with Jelmyto. Tell your healthcare provider right away if you become pregnant or think you may be pregnant during treatment with Jelmyto.
    Females who are able to become pregnant: You should use effective birth control (contraception) during treatment with Jelmyto and for 6 months after the last dose.
    Males being treated with Jelmyto: If you have a female partner who is able to become pregnant, you should use effective birth control (contraception) during treatment with Jelmyto and for 3 months after the last dose.
  • are breastfeeding or plan to breastfeed. It is not known if Jelmyto passes into your breast milk. Do not breastfeed during treatment with Jelmyto and for 1 week after the last dose.
  • Tell your healthcare provider if you take water pills (diuretic).
How will I receive Jelmyto?
  • Your healthcare provider will tell you to take a medicine called sodium bicarbonate before each Jelmyto treatment.
  • You will receive your Jelmyto dose from your healthcare provider 1 time a week for 6 weeks. It is important that you receive all 6 doses of Jelmyto according to your healthcare provider’s instructions. If you miss any appointments, call your healthcare provider as soon as possible to reschedule your appointment. Your healthcare provider may recommend up to an additional 11 monthly doses.
  • Jelmyto is given to your kidney through a tube called a catheter.
  • During treatment with Jelmyto, your healthcare provider may tell you to take additional medicines or change how you take your current medicines.
After receiving Jelmyto:
  • Jelmyto may cause your urine color to change to a violet to blue color. Avoid contact between your skin and urine for at least 6 hours.
  • To urinate, males and females should sit on a toilet and flush the toilet several times after you use it. After going to the bathroom, wash your hands, your inner thighs, and genital area well with soap and water.
  • Clothing that comes in contact with urine should be washed right away and washed separately from other clothing.
Jelmyto may cause serious side effects, including:
  • Swelling and narrowing of the tube that carries urine from the kidney to the bladder (ureteric obstruction). If you develop swelling and narrowing, and to protect your kidney from damage, your healthcare provider may recommend the placement of a small plastic tube (stent) in the ureter to help the kidney drain. Tell your healthcare provider right away if you develop side pain or fever during treatment with Jelmyto.
  • Bone marrow problems. Jelmyto can affect your bone marrow and can cause a decrease in your white blood cell, red blood cell, and platelet counts. Your healthcare provider will do blood tests prior to each treatment to check your blood cell counts during treatment with Jelmyto. Your healthcare provider may need to temporarily or permanently stop Jelmyto if you develop bone marrow problems during treatment with Jelmyto.

The most common side effects of Jelmyto include: urinary tract infection, blood in your urine, side pain, nausea, trouble with urination, kidney problems, vomiting, tiredness, stomach (abdomen) pain.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit http://www.fda.gov/medwatch or call 1-800-FDA-1088. You may also report side effects to UroGen Pharma at 1-855-987-6436.

Please click here for Jelmyto Full Prescribing Information, including the Patient Information, for additional information.